ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726863 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726863; 2) Community: the network communities that were significantly associated with the response to NSC 726863; 3) Molecule: the relationships between components within communities and NSC 726863; 4) MDR: the compounds that were significantly associated with the NSC 726863.

NSC Compound Enrichment Correlation
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0490935610249067 0.3655671
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0490935610249067 0.31455368
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0490935610249067 0.43497766
NSC 619030 Analog of CC-1065 0.0490935610249067 0.31950576
NSC 636969 Null 0.0490935610249067 0.36492319
NSC 63878 Cytarabine Hydrochloride AZ 0.0490935610249067 0.41440061
NSC 641454 3'-O-(Dimethylaminoethylcarbonyl)-(Z)-combretastatin A-4 0.0490935610249067 0.19823325
NSC 646140 Null 0.0490935610249067 0.21275943
NSC 658143 2-(1-(4-(2-(2-Hydroxyethoxy)ethyl)piperazino))naphthazarin 0.0490935610249067 0.30872317
NSC 661581 2-Azabicyclo[16.3.1]docosane, geldanamycin deriv. 0.0490935610249067 0.35267726
Total:48  Current:46    [First] [Prev] [Next] [Last]